References
- Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart G. In: Methods for the Economic Evaluation of Healthcare Programmes. Oxford University Press, Oxford, UK (2005).
- Blumstein J. The Oregon Experiment: The role of cost-benefit analysis in the allocation of Medicaid funds. Soc. Sci. Med. 45, 545–554 (1997).
- Devlin N, Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis. Health Econ. 13, 437–452 (2004).
- Evans C, Tavakoli M, Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal. Health Care Manag. Sci. 7(1), 43–49 (2004).
- Barbieri M, Drummond M, Willke R, Chancellor J, Jolain B, Towse A. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability. Value Health 8(1), 10–23 (2005).
- Rawlins M, Culyer A. National Institute for Clinical Excellence and its value judgements. Br. Med. J. 329, 224–227 (2004).
- Dolan P, Tsuchiya A, Armitage C et al. What is the value to society of a QALY? A protocol to determine the relative value of a QALY according to various health and non-health characteristics. In: NICE and NCCRM Tender. Sheffield Health Economics Group, School of Health and Related Research (ScHARR), UK (2005).
- Baker R, Chilton S, Donaldson C et al. Determining the societal value of a QALY by surveying the public in England and Wales: a research protocol. In: Submission to National Institute for Clinical Excellence and National Co-ordinating Centre for Research Methodology. School of Population & Health Sciences and The Business School, University of Newcastle upon Tyne, UK (2005).
- Bateman I, Loomes G, Mugford M et al. In:What is the Value to Society of a QALY? Issues Raised and Recommendations for How to Address Them. Report for National Institute of Clinical Excellence (NICE) and National Co-ordinating Centre for Research Methodology (NCCRM). School of Economics and Social Studies, UEA Norwich, UK (2003).
- Richardson J, Smith RD. Calculating society’s willingness to pay for a QALY. Key questions for discussion. Appl. Health Econ. Health Policy 3(3), 125–126 (2004).
- Petrou S. Preference-based approaches to measuring the benefits of perinatal care. Birth 30(4), 217–226 (2003).
- Grewel I, Lewis J, Flynn T, Brown J, Bond J, Coast J. Developing attributes for a generic quality of life measure for older people: Preferences or capabilities? Soc. Sci. Med. (In press) (2005).
- Petrou S. Methodological issues raised by preference-based approaches to measuring the health status of children. Health Econ. 12, 697–702 (2003).
- Tsuchiya A, Dolan P, Shaw R. Measuring people’s preferences regarding ageism in health: some methodological issues and some fresh evidence. Soc. Sci. Med. 57, 687–696 (2003).
- Dolan P, Shaw R, Tsuchiya A, Williams A. QALY maximisation and people’s preferences: a methodological review of the literature. Health Econ. 14, 197–208 (2005).
- Coast J. Is economic evaluation in touch with society’s health values? Br. Med. J. 329, 1233–1236 (2004).
- McDonald R. In: Using Health Economic in Health Services. Rationing Rationally? Open University Press, Buckingham, UK (2002).